Benefits
Weight Management with Enhanced Bioavailability
GarCitrin combines HCA (active compound for fat metabolism and appetite) with BioPerine for enhanced bioavailability — addresses absorption limitations of standalone Garcinia products.
Appetite Control and Satiety
HCA component provides documented satiety effects via serotonin pathway; modest food intake reduction in clinical trials.
Carbohydrate-to-Fat Conversion Inhibition
HCA inhibits ATP-citrate lyase enzyme reducing carbohydrate conversion to stored fat; mechanism distinct from appetite suppression.
BioPerine Bioavailability Enhancement
Piperine component enhances absorption of HCA and supports overall metabolic effects.
Patented Sabinsa Combination
Sabinsa's patented GarCitrin formulation provides specific HCA + piperine ratio with research backing.
Mechanism of action
ATP-Citrate Lyase Inhibition (HCA)
Same as Super CitriMax — HCA inhibits ATP-citrate lyase reducing fatty acid synthesis from carbohydrates.
Serotonin / Satiety Pathway
HCA modulates serotonin pathway — relevant to satiety and food cravings.
BioPerine Bioavailability Enhancement
Piperine inhibits CYP3A4 and P-glycoprotein — enhances absorption of co-administered HCA.
Combined Fat Metabolism Support
Multi-pathway approach to weight management vs single-mechanism ingredients.
Clinical trials
Sabinsa clinical studies of GarCitrin formulation for weight management.
Adults with weight management concerns.
Improvements in body composition markers and satiety.
General Garcinia/HCA evidence base across multiple branded forms.
Various populations.
Modest weight management effects; effect size variable; bioavailable forms more reliable.